Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Aug 24 | QNCX Quince Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.7 | 77,000 | 53.90 k | 843,941 |
29 Aug 24 | QNCX Quince Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.69 | 77,500 | 53.47 k | 766,941 |
1 Feb 24 | QNCX Quince Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.31 | 1,500,000 | 1.97 mm | 1,500,000 |
16 Jan 24 | QNCX Quince Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.94 | 149,999 | 141.00 k | 689,441 |
16 Jan 24 | QNCX Quince Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0.55 | 90,531 | 49.79 k | 539,442 |
16 Jan 24 | QNCX Quince Therapeutics | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.94 | 149,999 | 141.00 k | 450,001 |
16 Jan 24 | QNCX Quince Therapeutics | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.55 | 90,531 | 49.79 k | 115,860 |
10 Aug 23 | QNCX Quince Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.26 | 88,000 | 110.88 k | 448,911 |
8 Aug 23 | QNCX Quince Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.24 | 80,000 | 99.20 k | 360,911 |